AI-generated summary
The authors report a randomized controlled trial of 30 adults with chronic insomnia, comparing transcranial photobiomodulation with sham treatment over three days of frontal application. They report better sleep quality, less daytime sleepiness and changes in frontal delta power at one week in the active group, with no serious adverse events. The abstract notes the sample was small and that larger trials with longer follow-up are needed.
- Participants
- 30
- Who or what was studied
- Adults with chronic insomnia meeting DSM-5 criteria
- Wavelengths
- 810 nm
- Limits stated in the abstract
- The abstract notes that larger trials with longer follow-up are warranted, and the sample was small (30 participants, 15 per group).
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Transcranial photobiomodulation, Insomnia, Randomized controlled trial, Photobiomodulation, Electroencephalography, Fluence, Sham, Irradiance. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.